Highlights Calculation of patent term extension for drug products under regulatory review is based on the issue date of the original patent, not the reissue patent (if there is one), a recent court ...
The application states the device “can be folded to be compact, and...extended when increased screen size is desired.” ...
Jepson Claim Preamble Requires Written Description Support for Conventional Aspects of the Invention
Summary: To provide adequate written description for a Jepson claim, the applicant must establish that what is claimed to be well known in the prior art is, in fact, well known in the prior art.
It appears as though trademark woes keep haunting the Duchess of Sussex’s yet-to-be-released lifestyle brand — no matter the ...
The United States Patent and Trademark Office (USPTO) recently introduced a Continuing Application Fee (CAF) to address the growing backlog ...
David McCombs, Eugene Goryunov and Jonathan Bowser of Haynes Boone discuss collateral estoppel and when it might apply in a ...
This expected patent will enhance INBS’ existing intellectual property portfolio, which safeguards its unique fingerprint sweat-based drug screening technology. The anticipated grant will help ensure ...
On 20 March 2025, the Patent Trial and Appeal Board (PTAB) designated as “Informative” the majority opinion in the Decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback